* umbilical cord examination; * placental examination including histopathology (microscopic examination of placental tissue); and * verbal autopsy (interviews with care providers and support people to ascertain causes, without examination of the baby).
We planned to include trials assessing any test, protocol or guideline (or combinations of tests/protocols/guidelines) for investigating the causes of stillbirth, compared with the absence of a test, protocol or guideline, or usual care (further details are presented in the Background, see Description of the intervention).
We also planned to include trials comparing any test, protocol or guideline (or combinations of tests/protocols/guidelines) for investigating the causes of stillbirth with another, for example, the use of a limited investigation protocol compared with a comprehensive investigation protocol.
Data collection and analysis
Two review authors assessed trial eligibility independently.
Main results
We excluded five studies that were not RCTs. There were no eligible trials for inclusion in this review.
Authors' conclusions
There is currently a lack of RCT evidence regarding the effectiveness of interventions for investigating and identifying the causes of stillbirth. Seeking to determine the causes of stillbirth is an essential component of quality maternity care, but it remains unclear what impact these interventions have on the psychosocial outcomes of parents and families, the rates of diagnosis of the causes of stillbirth, and the care and management of subsequent pregnancies following stillbirth. Due to the absence of trials, this review is unable to inform clinical practice regarding the investigation of stillbirths, and the specific investigations that would determine the causes.
Future RCTs addressing this research question would be beneficial, but the settings in which the trials take place, and their design, need to be given careful consideration. Trials need to be conducted with the utmost care and consideration for the needs, concerns, and values of parents and families. Assessment of longer-term psychosocial variables, economic costs to health services, and effects on subsequent pregnancy care and outcomes should also be considered in any future trials.
P L A I N L A N G U A G E S U M M A R Y

Interventions for investigating and identifying the causes of stillbirth
What is the issue?
There are many causes of stillbirth, including the mother having high blood pressure or diabetes before the pregnancy, an infection such as malaria, HIV or syphilis, congenital abnormalities in the baby, issues with how well the placenta is functioning, and pregnancy continuing past the due date. Sometimes a baby dies as a result of multiple causes. The death of a baby to stillbirth is a devastating event for parents, families, and communities. To prevent stillbirths, we need to understand more about why they occur. Understanding why a baby died may also help parents to cope with their grief, and assist them in care planning for future pregnancies.
Many different tests and investigations can be done to help find out why a baby died. These tests and investigations differ in the level of expertise required, how invasive they are, and their economic costs. Tests, procedures or guidelines for investigating and identifying the causes of stillbirth include looking at the medical history of the parents, any problems during the pregnancy, maternal investigations (such as ultrasound, amniocentesis, antibody screening), examination of the stillborn baby, examination of the umbilical cord and placenta, and interviews with care providers and support people to determine causes without examination of the baby (verbal autopsy). Currently there is no standard approach to investigating the causes of stillbirth.
Why is this important?
Searching for causes of stillbirth can be difficult emotionally for families, and financially costly to health services and sometimes to parents. Some tests and investigations may be more helpful than others in identifying the causes of stillbirth. There is a need to assess systematically which approaches are most helpful in finding causes of stillbirth, how cost-effective the different approaches are, what the emotional and social effects on parents are, what impact the investigations have on future pregnancies, and the end result of future pregnancies.
What evidence did we find?
We searched for evidence on 15 May 2017. We did not find any trials for inclusion in this review. We excluded five trials because they were not randomised controlled trials.
What does this mean?
There is no evidence available to guide how best to investigate the causes of stillbirth. Seeking to determine the causes of a baby's death is an essential component of quality maternity care in any setting. Future trials on this topic would be helpful, but such trials would need to be designed in a way that ensures all parents in the trial still receive the minimum standard of care in their local setting. Future trials would need to be conducted with the utmost care and consideration for the needs, concerns, and values of parents and families. Assessment of longer-term psychosocial variables, economic costs to health services, and effects on subsequent pregnancy care and outcomes should be considered in any future trials.
B A C K G R O U N D Description of the condition
Stillbirth is associated with profound and long-lasting adverse psychosocial outcomes for families and care providers, along with wider economic impacts on health systems and society (Heazell 2016) . The global burden of stillbirth is high, with an estimated 2.6 million stillbirths (at 28 weeks' gestation or greater) occurring every year. Although many of these deaths are preventable, global reduction in stillbirth rates remains slow and has not matched declines in maternal or child mortality (Lawn 2016) . Accurate data on causes of stillbirth are limited, partly due to the difficulty in assigning causation, often owing to multifactorial circumstances (Silver 2007; Whitfield 1986) . The use of various, disparate classification systems for assigning cause of death also hampers understanding of causes at global and regional levels (Flenady 2015; Flenady 2017; Leisher 2016; Wojcieszek 2016) . Flenady 2016 showed wide variation in the contribution of different causes of stillbirth. For example, the proportion of stillbirths related to infection ranged from 5% to 22%, and the proportion of stillbirths related to congenital abnormalities ranged from 6% to 27%. "Unexplained" deaths were reported for up to 76% of cases, and showed particularly wide variation. In a global review of 85 national stillbirth reports across 50 countries, "unexplained" was the most commonly reported cause of death category among the 489,089 stillbirths included (Reinebrant 2017). Difficulties ascertaining causes of death are often compounded by limited availability of clinical information. In some low-and middle-income countries (LMICs), minimal or no diagnostic investigations are available (Flenady 2010; McClure 2018) . Many stillbirths are not reported, especially among the large proportion of births occurring outside formal health services. Despite these limitations, it is clear that over half of stillbirths (globally) are related to intrapartum complications, and that increased access to skilled birth attendants and emergency obstetric care could eliminate most of these deaths (Lawn 2016). Infections such as malaria and syphilis and placental conditions such as poor growth of the baby (also called fetal growth restriction (FGR)), placental abruption (when the placenta breaks away from the wall of the uterus), and pre-eclampsia (high blood-pressure and protein in the urine) are other commonly reported causes of stillbirth. Pre-existing hypertension and pre-existing diabetes are also common, important risk factors for stillbirth. These risk factors are often associated with obesity and maternal age over 35 years, which are independent risk factors for stillbirth that are also increasingly common throughout the developed and developing worlds (Flenady 2011). Other major risk factors for stillbirth include smoking, primiparity (where a woman is giving birth for the first time), multiple pregnancy, previous stillbirth (Flenady 2011), and post-term pregnancy (Flenady 2011; Lawn 2016) . Although the burden of stillbirth lies predominantly in LMICs, thousands of potentially preventable stillbirths also occur in highincome countries (HICs) (Flenady 2016) . In these settings, most stillbirths occur in the antenatal period, and are associated with placental dysfunction (Flenady 2016) . Disparities in stillbirth rates are clearly evident, with the risk of stillbirth among disadvantaged women roughly double that of more advantaged women (Flenady 2016).
Description of the intervention
Accurate determination of causes and contributing factors is needed to reduce stillbirth rates. To identify causes of death, collection of data related to the stillbirth, such as demographic data, maternal risk factors and labour and birth information are required (Barfield 2011; Flenady 2018) . A range of investigations, as described in further detail below, may also be used. This review focused on interventions for investigating and identifying the causes of stillbirth. Such interventions are diverse, but may include:
• review of maternal and family history, and current pregnancy and birth history;
• clinical history of present illness;
• maternal investigations (such as ultrasound, amniocentesis, antibody screening, etc);
• examination of the stillborn baby (including full autopsy, partial autopsy or noninvasive components, such as magnetic resonance imaging (MRI), computerised tomography (CT) scanning, and radiography);
• umbilical cord examination;
• placental examination including histopathology (microscopic examination of placental tissue); and
• verbal autopsy (interviews with care providers and support people to ascertain causes, without examination of the baby).
Among the investigations available to parents and clinicians, autopsy is considered the 'gold standard' in determining causes of death (Alderliesten 2003; Lyon 2004; Rose 2006) . Autopsy can identify a wide range of causes of stillbirth, including infection, anaemia, and morphologic (structural) and metabolic (relating to metabolism) abnormalities (Silver 2007). However, there is variation in the reported yield of the procedure following a stillbirth (Gordijn 2002) . Furthermore, many factors influence parents' decision regarding whether to consent to autopsy (Breeze 2012), and some parents may decline to avoid subjecting their baby to invasive examination (Lyon 2004). Cultural and religious practices, such as the requirement of prompt burial or for the baby's body to be left undisturbed, or both, may also influence decision making (Gordijn 2007) . In many cases, whether to consent to an autopsy of their baby is one of the most difficult and pressing decisions facing parents immediately following stillbirth. The information and counselling parents receive at this time, and their interactions with care providers, can impact upon their grief and longer-term psychosocial functioning ( Other investigations that may be used in the routine evaluation of stillbirth include (but are not limited to) maternal thyroid, liver and kidney function tests, testing for gestational diabetes (Flenady 2018), toxicology screening (to detect maternal drug use), and tests for various infections and viruses (Silver 2007). Investigations to identify maternal antibodies and blood clotting disorders (thrombophilias) may be informative in some situations. As stated earlier, the ability to undertake certain investigations may be extremely limited in some settings, due to a lack of resources and low(er) attendance at health services (Flenady 2010). Financial costs incurred by health services can be a significant barrier to performing a thorough investigation following stillbirth. As shown in a UK study (Mistry 2013) , the cost of diagnostic investigations following stillbirth may as high as GBP 1804 per pregnancy, with perinatal autopsy being the most costly component. Many such sophisticated diagnostic investigations are simply unavailable in LMICs. In these settings, verbal autopsy (involving interviews with care providers and support people, without examination of the baby) may be used as an indirect method of ascertaining cause of death (Nausheen 2013). Therefore, it is also important to identify which tests are feasible in a setting where economic cost and access to equipment are barriers.
How the intervention might work
A high-quality investigation into the causes of stillbirth will ideally place minimal emotional and financial burden on parents, staff, and health services, while maintaining high diagnostic yield (Corabian 2005; Lim 2005; Silver 2007) . A number of formal protocols are currently in use to standardise investigations following stillbirth but, as shown in a systematic review (Corabian 2005) , there is large variation in the investigations that may be recommended. A specific comprehensive investigation protocol has previously been shown to be cost-effective when incorporated into routine stillbirth evaluation ( Accurate identification of causes of stillbirth may not only aid in emotional closure for parents, it may also provide a platform for clinical management in subsequent pregnancies (Flenady 2018; Michalski 2002; Silver 2007) . Indeed, the need for information to plan future pregnancies is one of the most important factors that influences parents' decision regarding whether to have an autopsy of their baby (Breeze 2012) and is highly likely to affect their satisfaction with care. The identification of a known recurrent cause of death, or an unexplained death despite thorough investigation, may prompt additional testing and surveillance in subsequent pregnancies (Mistry 2013). In contrast, the identification of a known non-recurrent cause may reassure parents and spare them from unnecessary testing and intervention in subsequent pregnancies (Silver 2007) . The Mistry 2013 study showed pregnancies subsequent to stillbirths that were unexplained or had known recurrent causes were GBP 500 more costly than pregnancies subsequent to stillbirths due to known non-recurrent causes. The study suggested that while a comprehensive workup of stillbirth may bring a higher initial cost to health systems, the economic costs of care in subsequent pregnancies may be reduced if investigations can exclude recurrent causes and reduce unexplained deaths (Mistry 2013). Importantly, the quality of the postmortem investigation and report, regardless of the investigations performed, will affect the likelihood of yielding clinically meaningful information (Cartlidge 1995; Corabian 2005) .
Why it is important to do this review
The prevention of stillbirth requires an understanding of its causes. Understanding of the causes of stillbirth is also critical to the psychosocial well-being of bereaved parents, and to the planning of management of their subsequent pregnancies, including counselling about recurrence risks. Diagnostic investigations aim to meet these needs, but there is currently no consensus on the optimal approach to investigations, including even the most basic set of key minimal investigations recommended (Korteweg 2012; Lim 2005) . Given the wide variety of investigations that are potentially available, their economic cost, and potential to add further to parents' emotional burden, there is a need to systematically assess the effect of these interventions on outcomes for families, including psychosocial outcomes, and on rates of diagnosis of the causes of stillbirth.
O B J E C T I V E S
To assess the effect of different tests, protocols or guidelines for investigating and identifying the causes of stillbirth on outcomes for parents, including psychosocial outcomes, economic costs, and rates of diagnosis of the causes of stillbirth.
M E T H O D S
Criteria for considering studies for this review 
Types of studies
We planned to include randomised controlled trials (RCTs), quasi-RCTs, and cluster-RCTs. We excluded cross-over trials. We planned to include studies published as abstract only, provided there was sufficient information to allow us to assess study eligibility.
Types of participants
We planned to include parents (including mothers, fathers, and partners) who had experienced a stillbirth of 20 weeks' gestation or greater.
Types of interventions
We planned to include trials assessing any test, protocol or guideline (or combinations of tests/protocols/guidelines) for investigating the causes of stillbirth, compared with the absence of a test, protocol or guideline, or usual care (see Description of the intervention for further details about types of tests or investigations that might be included in protocols or guidelines). We also planned to include trials comparing any test, protocol or guideline (or combinations of tests/protocols/guidelines) for investigating the causes of stillbirth with another (for example, the use of a limited investigation protocol compared with a comprehensive investigation protocol).
Types of outcome measures
No core outcomes were identified for this review topic. We therefore selected a range of important outcomes with respect to the effects of investigations, as below.
Primary outcomes
• Change in the final cause(s) of death from the presumed or clinical a priori cause of death.
• Final cause(s) of death unknown.
• Additional parental counselling or subsequent pregnancy care information (e.g. determination of or change in recurrence risk; exclusion of suspected causes of death; exclusion of recurrent causes of death; or combination of these).
• Parental satisfaction with the process and outcomes of investigations.
Secondary outcomes
In postpartum period
• Confirmation of clinical diagnosis.
• Attainment of unexpected findings.
• Exclusion of suspected causes of death.
• Exclusion of recurrent causes of death.
• Compliance with test/protocol/guideline.
• Parental understanding of the cause(s) of death.
• Parental regret about the investigations performed.
• Parental attitudes towards process and outcomes of investigations.
• Parental psychosocial outcomes including anxiety and quality of life.
• Parental satisfaction with care around the time of death and at follow-up.
• Care provider satisfaction with the process and outcomes of investigations.
• Frequency of investigations performed, e.g. maternal and family history; maternal investigations prior to birth; stillborn examination; umbilical cord examination; placental examination.
• Costs of investigations (economic).
In subsequent pregnancy
• Stillbirth.
• Neonatal death.
• Preterm birth.
• Induction of labour.
• Caesarean birth.
• Low birthweight.
• Parental anxiety.
• Costs of the subsequent pregnancy (economic).
Search methods for identification of studies
The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth.
Electronic searches
We searched Cochrane Pregnancy and Childbirth's Trials Register by contacting their Information Specialist (31 August 2017). The Register is a database containing over 23,000 reports of controlled trials in the field of pregnancy and childbirth. For full search methods used to populate Pregnancy and Childbirth's Trials Register including the detailed search strategies for CENTRAL, MED-LINE, Embase and CINAHL; the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service, please follow this link to the editorial information about the Cochrane Pregnancy and Childbirth in the Cochrane Library and select the 'Specialized Register' section from the options on the left side of the screen. Briefly, Cochrane Pregnancy and Childbirth's Trials Register is maintained by their Information Specialist and contains trials identified from: Search results were screened by two review authors and the full text of all relevant trial reports identified through the searching activities described above were reviewed. Based on the intervention described, each trial report was assigned a number that corresponds to a specific Pregnancy and Childbirth review topic (or topics), and was then added to the Register. The Information Specialist searched the Register for each review using this topic number rather than keywords. This resulted in a more specific search and any search results would have been fully accounted for in the relevant review sections (Included, Excluded, Awaiting Classification or Ongoing). In addition, we searched ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform ( ICTRP) for unpublished, planned and ongoing trial reports on 15 May 2017 using the terms in Appendix 1.
Searching other resources
We planned to search the reference lists of retrieved studies for further eligible studies. We did not apply date or language restrictions to any searches.
Data collection and analysis
No eligible studies were identified by the search for this version of the review, but for future updates, we plan to use the methods outlined in Appendix 2. These methods are based on a standard template used by Cochrane Pregnancy and Childbirth.
R E S U L T S Description of studies
Results of the search
There were no eligible trials identified from the search strategy within the Cochrane Pregnancy and Childbirth's Trials Register. We retrieved 224 records from ClinicalTrials.gov, equating to 152 trials when duplicates were removed. We retrieved 46 records from ICTRP, equating to 23 trials when duplicates were removed. All records were screened-out or excluded based on full-text review (see Figure 1) . 
Excluded studies
Five records underwent full-text review and were excluded based on study design/failure to meet eligibility criteria (see Characteristics of excluded studies). One of these studies ( Brasseur-Daudruy 2014), a non-randomised trial assessing the effectiveness of MRI as a diagnostic tool following intrauterine fetal death, has since been discontinued due to low recruitment. Another non-randomised trial (Rüegger 2014) is currently assessing the yield of minimally invasive or 'virtual autopsy' (a combination of postmortem imaging and imaging-guided biopsies) as compared to conventional autopsy. It is expected that this study will be completed in 2018.
Risk of bias in included studies
Not applicable.
Effects of interventions
D I S C U S S I O N
There is currently a lack of randomised controlled trial evidence regarding the effectiveness of interventions for investigating and identifying causes of stillbirth. Seeking to understand the causes of stillbirth is fundamental to quality maternity care, but it remains unclear what effect these interventions have on certain outcomes, including psychosocial outcomes for parents and families, rates of diagnosis of the causes of stillbirth, and subsequent pregnancy care and management. This review highlights the challenges clinicians and researchers face in developing high-quality clinical practice guidelines to guide the investigation of stillbirths.
On the basis of other literature (assessing non-randomised studies), fundamental components of the investigation of stillbirths appear to include comprehensive maternal (medical, social, family) and pregnancy history, and external examination of the baby. Even where not diagnostic in isolation, these investigations may be highly informative in directing further testing. Perinatal autopsy is often a highly important investigation ( Until appropriately designed randomised controlled trials have been conducted, clinical guidelines regarding approaches to the investigation of stillbirth may continue to be based upon the information yielded from such existing non-randomised studies, most of which are specific to high-income countries.
A U T H O R S ' C O N C L U S I O N S Implications for practice
Due to the absence of randomised controlled trials, this review is unable to inform clinical practice regarding the effectiveness of interventions for investigating and identifying causes of stillbirth.
Implications for research
High-quality clinical trials are needed to measure the effectiveness of interventions for investigating and identifying the causes of stillbirth. However, there are difficulties in conducting randomised trials addressing this research question, due to its ethical and practical complexities. As such, the design of future trials would need to be considered carefully, ensuring that the current standard of care in a given local setting is maintained. It may be appropriate to evaluate a comprehensive investigation protocol against a selective protocol where, in the latter, investigations are limited to those that appear warranted on the basis of clinical history or the suspected diagnosis, or both. Another trial design may involve randomising to a conceal versus reveal protocol, where all pertinent investigations are carried out (and results shared with parents), but the information yielded from certain investigations is either provided or withheld from a panel of experts, depending on the intervention arm.
With either of the options outlined above, trialists would need to ensure clinical equipoise in the given approaches to investigation, both from an ethical standpoint, and to aid in the recruitment of trial participants. Although it was excluded from the current review on the basis of study design, the discontinued Brasseur-Daudruy 2014 trial highlights the difficulties researchers face in recruiting participants for trials addressing this research question. Therefore, depending on the setting, the need for clinical equipoise may preclude certain types of intervention arms/investigation protocols, such as any that were deemed to be at risk of missing an important diagnosis. Trials evaluating a new investigation protocol against no intervention may be highly informative, but would only be feasible and appropriate in settings where no or minimal stillbirth investigations are currently offered (such as in some low-and middle-income countries (LMICs)).
Notwithstanding, any such trials must be conducted with the utmost care and consideration for the needs, concerns, and values of parents, and should be designed in such a way to allow follow-up and assessment of longer-term psychosocial variables, economic costs to health services, and effects on subsequent pregnancy care and outcomes. Effective methods for communicating with bereaved parents about stillbirth risk factors and recommendations for subsequent pregnancy care, based upon the findings of investigations, should also be explored.
There remains a place for a series of Cochrane Diagnostic Test Accuracy reviews in the context of perinatal death, to understand precisely how well specific diagnostic investigations perform in their capacity to discriminate accurately between the true presence and absence of specific conditions (e.g. fetal-maternal haemorrhage). For such reviews to be carried out, an appropriate reference standard would need to be identified and clearly defined. Such a reference standard might be comprehensive autopsy by a skilled perinatal pathologist coupled with placental examination and histopathology. The influence of subjective clinical criteria for diagnosing certain conditions (e.g. gestational diabetes) should also be assessed.
New software programs enabling quantitative, objective assessment of placental tissue have been reported (Kidron 2017; Ptacek 2016) . The use of image analysis software may provide additional information to that received from qualitative assessment alone. Such techniques may assist with standardisation of placental histological examination, but further research into their diagnostic utility is needed (Kidron 2017). Economic costs and feasibility also need to be considered. Developing basic minimal practices for identifying causes of stillbirths in LMICs also remains a priority. 
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C H A R A C T E R I S T I C S O F S T U D I E S
Appendix 2. Methods to be used in future updates
• high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; 'as treated' analysis done with substantial departure of intervention received from that assigned at randomisation);
• unclear risk of bias.
Selective reporting (checking for reporting bias)
We will describe for each included study how we investigated the possibility of selective outcome reporting bias and what we found. We will assess the methods as:
• low risk of bias (where it is clear that all of the study's pre-specified outcomes and all expected outcomes of interest to the review have been reported);
• high risk of bias (where not all the study's pre-specified outcomes have been reported; one or more reported primary outcomes were not pre-specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported);
6. Other bias (checking for bias due to problems not covered by 1 to 5 above)
We will describe for each included study any important concerns we have about other possible sources of bias. We will assess whether each study was free of other problems that could put it at risk of bias:
• low risk of other bias;
• high risk of other bias;
• unclear whether there is risk of other bias.
Assessing the quality of the evidence using the GRADE approach
We will use the GRADE approach as outlined in the GRADE handbook in order to assess the quality of the body of evidence relating to the following outcomes for the main comparisons:
• change in the final cause(s) of death from the presumed or clinical a priori cause of death;
• final cause(s) of death unknown; • additional parental counselling or subsequent pregnancy care information (e.g. determination of or change in recurrence risk; exclusion of suspected causes of death; exclusion of recurrent causes of death; or combination of these);
• parental satisfaction with the process and outcomes of investigations;
• compliance with test/protocol/guideline; • costs of investigations (economic); and • stillbirth (in the subsequent pregnancy).
We will use the GRADEpro Guideline Development Tool to import data from Review Manager 5.3 (Review Manager 2014) in order to create 'Summary of findings' tables. A summary of the intervention effect and a measure of quality for each of the above outcomes will be produced using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias.
Measures of treatment effect Dichotomous data
For dichotomous data, we will present results as summary risk ratio with 95% confidence intervals.
Continuous data
For continuous data, we will use the mean difference if outcomes are measured in the same way between trials. We will use the standardised mean difference to combine trials that measure the same outcome, but use different methods.
